Starling Oncology Statistics
NASDAQ: STLNHealth CareMedical/Nursing ServicesUSD
6.28-0.15 (-2.33%)
Market open · Delayed 15 min · as of Oct 8, 1:15 PM ET
Starling Oncology by the numbers
Starling Oncology has a market capitalization of $640.0 million based on 101.92M shares outstanding. With trailing EPS of $-0.29, Starling Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.4% above its 50-day average and 41.1% above its 200-day average.
Average daily trading volume is 1.54M shares, or about $9.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
STLN valuation vs. peer median
| Metric | STLN | Peer median | Difference |
|---|---|---|---|
| Market cap | $640.03M | $474.70M | +35% |
| Avg. volume | 1.54M | 519.65K | +196% |
Peer median across 8 companies: SBC, AHCO, SRTA, AUNA, TDOC, PIII, NAKA, LFMD.
Valuation
- Market cap
- $640.03M
- EPS (TTM)
- $-0.29
- Shares outstanding
- 101.92M
Price and trading
- Previous close
- 6.43
- Open
- 6.39
- Day range
- 6.20 – 6.41
- 52-week range
- 2.32 – 7.13
- 52-week change
- +68.32%
- Beta
- —
- Volume
- 445.24K
- Average volume
- 1.54M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 640.03M
- Eps
- -0.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.13
- Week52 Low
- 2.32
- Avg Volume
- 1.54M
- Shares Outstanding
- 101.92M
- Ma50
- 6.19
- Ma200
- 4.45
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -11.92%
- Pct From52w Low
- 170.69%